Lovesac Co reporting persons filed Amendment No. 1 to a Schedule 13G/A disclosing beneficial ownership positions in the issuer's Common Stock.
As of the close of business on April 28, 2026, the filing shows Philotimo owned 431 shares, PHLOX owned 923 shares, and both Kanen Wealth Management, LLC and David L. Kanen are reported as beneficial owners of 1,354 shares (aggregate group position 1,354 shares). The filing uses 14,617,106 shares outstanding as of February 1, 2026 as the denominator; the reported holdings are approximately 0% of outstanding shares.
Positive
None.
Negative
None.
Insights
Schedule 13G/A amendment documents small institutional holdings and group attribution.
The amendment clarifies beneficial ownership by Philotimo, its related series PHLOX, Kanen Wealth Management, LLC, and David L. Kanen as of April 28, 2026. It cites 14,617,106 shares outstanding as of February 1, 2026 to compute percentages.
The filing states the Reporting Persons form a group under Section 13(d)(3) and disclaims ownership beyond direct holdings; subsequent disclosures should follow if positions change above reporting thresholds.
Reported positions are immaterial to capitalization but clarify manager and affiliated-entity relationships.
The filing shows direct holdings of 431, 923, and an aggregate of 1,354 shares, tied to the manager/partner relationships between KWM, Philotimo and PHLOX. Percentages are reported using an issuer-stated outstanding share count.
Because the aggregate position is a vanishing fraction of 14,617,106 shares outstanding, the disclosure is routine; changes above regulatory thresholds would trigger updated filings.
Key Figures
Shares outstanding:14,617,106 sharesAggregate reported holdings:1,354 sharesPhilotimo holdings:431 shares+1 more
4 metrics
Shares outstanding14,617,106 sharesas of February 1, 2026
Aggregate reported holdings1,354 sharesaggregate holdings by the Reporting Persons as of April 28, 2026
Philotimo holdings431 sharesbeneficially owned as of April 28, 2026
PHLOX holdings923 sharesbeneficially owned as of April 28, 2026
Key Terms
Schedule 13G/A, beneficially owned, Section 13(d)(3) group
3 terms
Schedule 13G/Aregulatory
"Amendment No. 1 to Schedule 13G/A disclosing beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially ownedregulatory
"As of the close of business on April 28, 2026: Philotimo beneficially owned 431 Shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Section 13(d)(3) groupregulatory
"Each Reporting Person is a member of a "group" with the other Reporting Persons for the purposes of Section 13(d)(3)"
What does the Lovesac (LOVE) Schedule 13G/A amendment disclose?
It discloses beneficial ownership by related reporting persons: Philotimo 431 shares, PHLOX 923 shares, and an aggregate 1,354 shares by affiliated entities as of April 28, 2026.
How large are the holdings reported relative to Lovesac's outstanding shares?
The filing uses an outstanding share count of 14,617,106 shares as of February 1, 2026; the reported aggregate 1,354 shares represent approximately 0% of outstanding shares.
Why are multiple entities listed together in this filing for LOVE?
The filing explains KWM is general partner of Philotimo and investment manager of PHLOX; these relationships cause the parties to be reported collectively as a group under Section 13(d)(3) for disclosure purposes.
Does this Schedule 13G/A indicate any trading activity by the reporting persons?
The amendment reports beneficial ownership amounts as of April 28, 2026. It does not state transaction dates, trade direction, or prices in the provided excerpt.
Who signed the Schedule 13G/A amendment for Lovesac (LOVE)?
The amendment is signed by David L. Kanen in his capacities as Managing Member of Kanen Wealth Management, LLC and on behalf of the related reporting persons, dated April 29, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Lovesac Co
(Name of Issuer)
Common Stock, $0.00001 par value per share
(Title of Class of Securities)
54738L109
(CUSIP Number)
04/28/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
54738L109
1
Names of Reporting Persons
Philotimo Fund, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
431.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
431.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
431.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
54738L109
1
Names of Reporting Persons
Philotimo Focused Growth & Income Fund
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
923.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
923.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
923.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
54738L109
1
Names of Reporting Persons
Kanen Wealth Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
FLORIDA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,354.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,354.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,354.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
54738L109
1
Names of Reporting Persons
Kanen David
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,354.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,354.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,354.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Lovesac Co
(b)
Address of issuer's principal executive offices:
421 ATLANTIC STREET, SUITE 200, 421 ATLANTIC STREET, SUITE 200, STAMFORD, CONNECTICUT, 06901.
Item 2.
(a)
Name of person filing:
This statement is filed by Philotimo Fund LP, a Delaware limited partnership (Philotimo), Philotimo Focused Growth & Income Fund, a series of World Funds Trust, a Delaware statutory trust (PHLOX), Kanen Wealth Management, LLC, a Florida limited liability company (KWM), and David L. Kanen. Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons."
KWM is the general partner of Philotimo and the investment manager of PHLOX and certain separately managed accounts (the KWM Managed Accounts). Mr. Kanen serves as the managing member of KWM. By virtue of these relationships, KWM and Mr. Kanen may be deemed to beneficially own the Common Stock, $0.00001 par value per share (the Shares), of Lovesac Co. (the Issuer), owned by each of Philotimo, PHLOX and the KWM Managed Accounts.
(b)
Address or principal business office or, if none, residence:
The principal business address of each of Philotimo, KWM, PHLOX and Mr. Kanen is 6810 Lyons Technology Circle, Suite 160, Coconut Creek, FL 33073.
(c)
Citizenship:
Philotimo is organized under the laws of the State of Delaware. PHLOX is a series of World Funds Trust, a statutory trust organized under the laws of the State of Delaware. KWM is organized under the laws of the State of Florida. Mr. Kanen is a citizen of the United States of America.
(d)
Title of class of securities:
Common Stock, $0.00001 par value per share
(e)
CUSIP No.:
54738L109
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of the close of business on April 28, 2026:
(i) Philotimo beneficially owned 431 Shares;
(ii) PHLOX beneficially owned 923 Shares;
(iii) KWM beneficially owned 1,354 Shares, consisting of (a) the 431 Shares owned directly by Philotimo, which KWM may be deemed to beneficially own as the general partner of Philotimo, (b) the 923 Shares owned directly by PHLOX, which KWM may be deemed to beneficially own as the investment manager of PHLOX;
(iv) Mr. Kanen beneficially owned 1,354 Shares, consisting of (a) the 431 Shares owned directly by Philotimo, which KWM may be deemed to beneficially own as the general partner of Philotimo, (b) the 923 Shares owned directly by PHLOX, which KWM may be deemed to beneficially own as the investment manager of PHLOX.
Each Reporting Person is a member of a "group" with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and such group may be deemed to beneficially own the 1,354 Shares beneficially owned in the aggregate by all the Reporting Persons, constituting approximately 0% of the outstanding Shares. Each Reporting Person disclaims beneficial ownership of the Shares that he or it does not directly own.
(b)
Percent of class:
The aggregate percentage of the Shares reported owned by each person named herein is based upon 14,617,106 Shares outstanding as of February 1, 2026, which is the total number of Shares outstanding as reported in the Issuer's Form 10-K filed with the Securities and Exchange Commission on April 2, 2026.
As of the close of business on April 28, 2026:
(i) Philotimo beneficially owned approximately 0% of the outstanding Shares;
(ii) PHLOX beneficially owned approximately 0% of the outstanding Shares;
(iii) KWM beneficially owned approximately 0% of the outstanding Shares; and
(iv) Mr. Kanen beneficially owned approximately 0% of the outstanding Shares.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Cover Pages Items 5-9.
(ii) Shared power to vote or to direct the vote:
See Cover Pages Items 5-9.
(iii) Sole power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
(iv) Shared power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on March 30, 2026.
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Philotimo Fund, LP
Signature:
/s/ David L. Kanen
Name/Title:
David L. Kanen, Managing Member or Kanen Wealth Management LLC, its general partner
Date:
04/29/2026
Philotimo Focused Growth & Income Fund
Signature:
/s/ David L. Kanen
Name/Title:
David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its investment manager
